| Symbol |
Name |
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABL2
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
|
ACACA
|
acetyl-CoA carboxylase alpha
|
|
ACTB
|
actin, beta
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ANAPC4
|
anaphase promoting complex subunit 4
|
|
ANAPC5
|
anaphase promoting complex subunit 5
|
|
APOE
|
apolipoprotein E
|
|
ARG2
|
arginase 2
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP6V0C
|
ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
|
AURKA
|
aurora kinase A
|
|
B2M
|
beta-2-microglobulin
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCLAF1
|
BCL2-associated transcription factor 1
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
CAMKK2
|
calcium/calmodulin-dependent protein kinase kinase 2, beta
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCL8
|
chemokine (C-C motif) ligand 8
|
|
CCNA2
|
cyclin A2
|
|
CCNE1
|
cyclin E1
|
|
CCNT1
|
cyclin T1
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD14
|
CD14 molecule
|
|
CD1D
|
CD1d molecule
|
|
CD209
|
CD209 molecule
|
|
CD28
|
CD28 molecule
|
|
CD38
|
CD38 molecule
|
|
CD4
|
CD4 molecule
|
|
CD83
|
CD83 molecule
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSNK2B
|
casein kinase 2, beta polypeptide
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP4F2
|
cytochrome P450, family 4, subfamily F, polypeptide 2
|
|
DAXX
|
death-domain associated protein
|
|
DDX39B
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EHMT2
|
euchromatic histone-lysine N-methyltransferase 2
|
|
EIF1AX
|
eukaryotic translation initiation factor 1A, X-linked
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
ERF
|
Ets2 repressor factor
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL2
|
coagulation factor II (thrombin) receptor-like 2
|
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3
|
|
FAS
|
Fas cell surface death receptor
|
|
FCN2
|
ficolin (collagen/fibrinogen domain containing lectin) 2
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
|
GATA2
|
GATA binding protein 2
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GMNN
|
geminin, DNA replication inhibitor
|
|
GZMM
|
granzyme M (lymphocyte met-ase 1)
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HOXB4
|
homeobox B4
|
|
HOXC4
|
homeobox C4
|
|
HOXC6
|
homeobox C6
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IFNL3
|
interferon, lambda 3
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IL10
|
interleukin 10
|
|
IL12B
|
interleukin 12B
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL32
|
interleukin 32
|
|
IL6
|
interleukin 6
|
|
IRF3
|
interferon regulatory factor 3
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB6
|
integrin, beta 6
|
|
JUN
|
jun proto-oncogene
|
|
KIR2DL1
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
|
|
KIR2DS5
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5
|
|
KLRC1
|
killer cell lectin-like receptor subfamily C, member 1
|
|
KLRC2
|
killer cell lectin-like receptor subfamily C, member 2
|
|
KLRD1
|
killer cell lectin-like receptor subfamily D, member 1
|
|
KLRG1
|
killer cell lectin-like receptor subfamily G, member 1
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MAVS
|
mitochondrial antiviral signaling protein
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MCM3AP
|
minichromosome maintenance complex component 3 associated protein
|
|
MCM4
|
minichromosome maintenance complex component 4
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR17
|
microRNA 17
|
|
MIR199A1
|
microRNA 199a-1
|
|
MIR20A
|
microRNA 20a
|
|
MIR92A1
|
microRNA 92a-1
|
|
MLXIPL
|
MLX interacting protein-like
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPLOC4
|
nuclear protein localization 4 homolog (S. cerevisiae)
|
|
PDCD1
|
programmed cell death 1
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PLA2G1B
|
phospholipase A2, group IB (pancreas)
|
|
PML
|
promyelocytic leukemia
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPIA
|
peptidylprolyl isomerase A (cyclophilin A)
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PSMD4
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 4
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PURA
|
purine-rich element binding protein A
|
|
PVR
|
poliovirus receptor
|
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B)
|
|
PXN
|
paxillin
|
|
RAB6A
|
RAB6A, member RAS oncogene family
|
|
RAE1
|
ribonucleic acid export 1
|
|
RAET1G
|
retinoic acid early transcript 1G
|
|
RB1
|
retinoblastoma 1
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RSAD2
|
radical S-adenosyl methionine domain containing 2
|
|
SERPINB9
|
serpin peptidase inhibitor, clade B (ovalbumin), member 9
|
|
SIRT1
|
sirtuin 1
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SNAPIN
|
SNAP-associated protein
|
|
SP100
|
SP100 nuclear antigen
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
STAT2
|
signal transducer and activator of transcription 2, 113kDa
|
|
STX3
|
syntaxin 3
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SUPT6H
|
suppressor of Ty 6 homolog (S. cerevisiae)
|
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TAPBP
|
TAP binding protein (tapasin)
|
|
TCEB2
|
transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THBS1
|
thrombospondin 1
|
|
THBS2
|
thrombospondin 2
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR9
|
toll-like receptor 9
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TP53
|
tumor protein p53
|
|
TYMS
|
thymidylate synthetase
|
|
UFD1L
|
ubiquitin fusion degradation 1 like (yeast)
|
|
ULBP2
|
UL16 binding protein 2
|
|
VCP
|
valosin containing protein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VIM
|
vimentin
|
|
XPO1
|
exportin 1
|
